Non categorizzato Eli Lilly to acquire Dice Therapeutics for $2.4B Giugno 20, 2023 0 commenti Eli Lilly and Co. announced on Tuesday it has agreed to buy biopharma company DICE Therapeutics Inc. for around $2.4 billion or $48 per share in cash to boost its autoimmune drug portfolio. “In … About the author:
Get involved!
Comments